Logo image
Friedreich Ataxia Clinical Outcome Measures: Natural History Evaluation in 410 Participants
Journal article   Peer reviewed

Friedreich Ataxia Clinical Outcome Measures: Natural History Evaluation in 410 Participants

Sean R Regner, Nicholas Wilcox, Lisa S Friedman, Lauren Seyer, Kim Schadt, Karlla W Brigatti, Susan Perlman, Martin Delatycki, George R Wilmot, Christopher M Gomez, …
Journal of child neurology, Vol.27(9), pp.1152-1158
09/2012
DOI: 10.1177/0883073812448462
PMCID: PMC3674496
PMID: 22752494

View Online

Abstract

Friedreich ataxia is an autosomal recessive neurodegenerative disorder characterized by ataxia, dysarthria, and areflexia. We report the progress of a large international non-interventional cohort (n = 410), tracking the natural history of disease progression using the neurological exam-based Friedreich Ataxia Rating Scale. We analyzed the rate of progression with cross-sectional analysis and longitudinal analysis over a 2-year period. The Friedreich Ataxia Rating Scale captured disease progression when used at 1 and 2 years following initial evaluation, with a lower ratio of standard deviation of change to mean change over 2 years of evaluation. However, modeling of disease progression identified substantial ceiling effects in the Friedreich Ataxia Rating Scale, suggesting this measure is most useful in patients before maximal deficit is approached.
clinical neurology Friedreich ataxia natural history study non-interventional study

Details

Logo image